Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373884

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373884

Global Auto Injector Market Size, Share, Growth Analysis, By Type, By Application, By End-user - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Auto Injector Market size was valued at USD 46.8 billion in 2021 and is poised to grow from USD 56.30 billion in 2022 to USD 247.3 billion by 2030, at a CAGR of 17.9% during the forecast period (2023-2030).

Autoinjectors are medical devices designed to deliver a specific dose of medication to patients. They are often used for the self-administration of drugs, such as epinephrine for severe allergic reactions or insulin for diabetes management. In recent years, the global auto injector market has experienced significant growth due to various factors, including the increasing prevalence of chronic diseases, rising demand for self-administration devices, and advancements in technology. Auto injectors offer several benefits, such as ease of use, accurate dosing, and improved patient compliance. Key players in the auto injector market include pharmaceutical companies, medical device manufacturers, and technology providers. These companies often compete in terms of product features, design, safety, and compatibility with different medications. Market dynamics, such as regulatory requirements, reimbursement policies, and patent protection, also influence the market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Auto-Injector Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Auto-Injector Market Segmental Analysis

The auto injectors market is segmented on the basis of type, application, end user, and region. By type, it is categorized into disposable and reusable auto injectors. Based on application, it is divided into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and others. By end user, it is categorized into home care settings and hospitals & clinics. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Auto-Injector Market Dynamics

Drivers of the Global Auto-Injector Market

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases, such as rheumatoid arthritis, multiple sclerosis, diabetes, and allergies, is a significant driver of the auto injector market. auto injectors offer a convenient and efficient way for patients to self-administer medications, empowering them to manage their conditions effectively.

There is a growing trend towards patient-centric healthcare, focusing on improving patient experience and promoting self-care. auto injectors provide patients with the ability to administer their medications at home, reducing the need for frequent hospital visits and enhancing their overall quality of life.

Restraints in the Global Auto Injector Market

High Cost of Auto Injectors

The cost of auto injector devices can be a restraint for market growth, particularly in emerging economies where affordability may be a concern for patients. The higher price of auto injectors compared to traditional syringes can limit their adoption in certain markets.

Despite the convenience they offer, auto injectors still involve needle usage, which can raise concerns about the risk of needlestick injuries. These safety concerns may limit their adoption, especially among patients who may be hesitant to self-administer injections.

Market Trends of the Global Auto Injector Key

The market is witnessing a notable trend towards self-administration of medications. Patients are increasingly seeking greater control and convenience in managing their treatment, leading to a rise in the adoption of auto injectors. These devices allow patients to self-administer medications accurately and easily, empowering them to take an active role in their healthcare journey.

Product Code: SQMIG35B2104

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Auto Injector Market by Type
    • Market Overview
    • Disposable and reusable auto injectors
  • Global Auto Injector Market by Application
    • Market Overview
    • Rheumatoid arthritis
    • multiple sclerosis
    • anaphylaxis
    • and others
  • Global Auto Injector Market by End-user
    • Market Overview
    • Home care settings and hospitals & clinics others
  • Global Auto Injector Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eli Lilly and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Amgen Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mylan N.V. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Antares Pharma, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bespak Europe Ltd. (A Consort Medical Company), (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SHL Medical AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Owen Mumford Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Enable Injections (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ScPharmaceuticals Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Biogen Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Consort Medical plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Haselmeier AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!